2010 AHA ECC Guidelines – Interview with Monica Kleinman, M.D. and Jamie Davis

I had the privilege of participating in a discussion about the new 2010 AHA ECC Guidelines with Jamie Davis (the “podmedic”) and Monica Kleinman, M.D., the incoming Chair of the ECC Committee.

You can listen to the podcast here:

Emergency Cardiovascular Care 2010 Update Interview

Special thanks to Dave Hiltz and Kate Lino of the AHA for their assistance in setting up the interview.

1 Comment

  • Jesse says:

    It was my understanding that adenosine was contraindicated in the presence of an accessory pathway (AVRT). While the minority theory is that it would break the tachycardia by blocking the AV node, the majority opinion is that it would promote use of the accessory pathway (although I don’t know how it re-enters the atrium) and in fact worsen the tachycardia.

    I’ve never actually tested either theory personally, so I’ve just stuck with what I was taught: Adenosine + AVRT = Bad.

    As AVRT’s (such as WPW) can appear with a very rapid rate, and with a regular, monomorphic wide complex, how might this be affected by the “trial of adenosine” suggestion for regular monomorphic WCT’s?

    Is a delta wave always going to be distinguishable?

Leave a Reply

Your email address will not be published. Required fields are marked *